In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials (PDQ®)

  • First Published: 4/2/2007
  • Last Modified: 2/8/2012

Page Options

  • Print This Page
  • Email This Document
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat
Prospective Study of Ototoxicity Assessment in Younger Cancer Patients Treated With Cisplatin

Alternate Title
Basic Trial Information
Objectives
Entry Criteria
Expected Enrollment
Outcomes
Outline
Trial Contact Information
Registry Information

Alternate Title

Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
No phase specifiedNatural history/Epidemiology, Supportive careActive1 to 18NCICOG-ACCL05C1
ACCL05C1, NCT00458887

Objectives

  1. Determine the optimal criteria for determination of ototoxicity in younger cancer patients treated with cisplatin.
  2. Determine the feasibility of including ultrahigh frequency and evoked otoacoustic emission testing as adjunctive measures of ototoxicity.
  3. Determine the feasibility and necessity of central review of audiometry data.

Entry Criteria

Disease Characteristics:

  • Planning to undergo treatment with any cisplatin-containing therapeutic regimen for cancer
    • Treatment does not need to be on a COG therapeutic study
  • Planning to enroll on clinical trial ACCL0431

Prior/Concurrent Therapy:

  • See Disease Characteristics
  • No prior cisplatin

Patient Characteristics:

  • Not specified

Expected Enrollment

327

A total of 282 patients will be accrued for this study.

Outcomes

Primary Outcome(s)

Incidence of patients with ototoxicity according to Common Toxicity Criteria, American-Speech-Language-Hearing Association, and Brock's criteria
Proportion of patients who undergo assessments using ultrahigh frequency (UHF) and evoked otoacoustic emission (OAE) testing
Proportion of patients with complete standard audiometry data (excluding UHF and OAE evaluations)

Outline

This is a multicenter, prospective, cohort study.

Patients undergo hearing tests (conventional, otoscopy, ultrahigh frequency, and otoacoustic emission testing) before the first course of planned cisplatin, before each subsequent course of cisplatin, and 4 weeks after the last dose of cisplatin.

Patients who are scheduled to receive hematopoietic progenitor stem cell transplantation undergo hearing tests before the transplantation and 4 weeks after transplantation.

Trial Contact Information

Trial Lead Organizations

Children's Oncology Group

Lillian Sung, MD, PhD, Protocol chair
Ph: 416-813-5287

Trial Sites

U.S.A.
Alabama
  Birmingham
 UAB Comprehensive Cancer Center
 Clinical Trials Office - UAB Comprehensive Cancer Center
Ph: 205-934-0309
Arkansas
  Little Rock
 Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
 Clinical Trial Office - Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Ph: 501-686-8274
California
  Los Angeles
 Childrens Hospital Los Angeles
 Leo Mascarenhas
Ph: 323-361-2529
 Southern California Permanente Medical Group
 Robert Cooper
Ph: 323-783-5307
  Madera
 Children's Hospital Central California
 Vonda Crouse
Ph: 559-353-5480
  Palo Alto
 Lucile Packard Children's Hospital at Stanford University Medical Center
 Neyssa Marina
Ph: 650-723-5535
  San Diego
 Rady Children's Hospital - San Diego
 Clinical Trials Office - Rady Children's Hospital - San Diego
Ph: 858-966-5934
  San Francisco
 UCSF Helen Diller Family Comprehensive Cancer Center
 Clinical Trials Office - UCSF Helen Diller Family Comprehensive Cancer Center
Ph: 877-827-3222
Connecticut
  Hartford
 Connecticut Children's Medical Center
 Clinical Trials Office - Connecticut Children's Medical Center
Ph: 860-545-9967
  New Haven
 Yale Cancer Center
 Clinical Trials Office - Yale Cancer Center
Ph: 203-785-5702
Delaware
  Wilmington
 Alfred I. duPont Hospital for Children
 Clinical Trials Office - Alfred I. duPont Hospital for Children
Ph: 302-651-5755
District of Columbia
  Washington
 Children's National Medical Center
 Clinical Trials Office - Children's National Medical Center
Ph: 202-884-2549
Florida
  Fort Myers
 Lee Cancer Care of Lee Memorial Health System
 Clinical Trials Office - Lee Cancer Care of Lee Memorial Health System
Ph: 877-680-0008
  Jacksonville
 Nemours Children's Clinic
 Eric Sandler
Ph: 904-697-3793
  Miami
 University of Miami Sylvester Comprehensive Cancer Center - Miami
 University of Miami Sylvester Comprehensive Cancer Center Clinical Trial Matching Service
Ph: 866-574-5124
  Email: Sylvester@emergingmed.com
  Orlando
 Florida Hospital Cancer Institute at Florida Hospital Orlando
 Clinical Trials Office - Florida Hospital Cancer Institute
Ph: 407-303-5623
 Nemours Children's Clinic - Orlando
 Ramamoorthy Nagasubramanian
Ph: 407-650-7230
  Pensacola
 Nemours Children's Clinic - Pensacola
 Jeffrey Schwartz
Ph: 850-505-4790
  Saint Petersburg
 All Children's Hospital
 Gregory Hale
Ph: 727-767-4176
  Tampa
 St. Joseph's Cancer Institute at St. Joseph's Hospital
 Clinical Trials Office - St. Joseph's Cancer Institute
Ph: 800-882-4123
Hawaii
  Honolulu
 Cancer Research Center of Hawaii
 Clinical Trials Office - Cancer Research Center of Hawaii
Ph: 808-586-2979
Idaho
  Boise
 Mountain States Tumor Institute at St. Luke's Regional Medical Center
 Eugenia Chang
Ph: 208-381-2731
Illinois
  Chicago
 University of Illinois Cancer Center
 Clinical Trial Office - University of Illinois Cancer Center
Ph: 312-355-3046
  Peoria
 Saint Jude Midwest Affiliate
 Pedro De Alarcon
Ph: 309-655-4242
Indiana
  Indianapolis
 Riley's Children Cancer Center at Riley Hospital for Children
 James Croop
Ph: 317-274-8784
Iowa
  Des Moines
 Blank Children's Hospital
 Clinical Trials Office - Blank Children's Hospital
Ph: 515-241-6729
  Iowa City
 Holden Comprehensive Cancer Center at University of Iowa
 Cancer Information Service
Ph: 800-237-1225
Kentucky
  Louisville
 Kosair Children's Hospital
 Clinical Trials Office - Kosair Children's Hospital
Ph: 502-629-5500
  Email: CancerResource@nortonhealthcare.org
Louisiana
  Alexandria
 Tulane Cancer Center Office of Clinical Research
 Clinical Trials Office - Tulane Cancer Center
Ph: 504-988-6121
  New Orleans
 Children's Hospital of New Orleans
 Clinical Trials Office - Children's Hospital of New Orleans
Ph: 504-894-5377
Maryland
  Bethesda
 National Naval Medical Center
 Melissa Forouhar
Ph: 253-968-6144
Michigan
  Ann Arbor
 C.S. Mott Children's Hospital at University of Michigan Medical Center
 Clinical Trials Office - C.S. Mott Children's Hospital
Ph: 1-800-865-1125
  Flint
 Hurley Medical Center
 Clinical Trials Office - Hurley Medical Center
Ph: 810-762-8057
  Grand Rapids
 Helen DeVos Children's Hospital at Spectrum Health
 Clinical Trials Office - Helen DeVos Children's Hospital
Ph: 616-391-3050
  Kalamazoo
 CCOP - Kalamazoo
 Jeffrey Lobel
Ph: 269-341-6350
Minnesota
  Minneapolis
 Children's Hospitals and Clinics of Minnesota - Minneapolis
 Clinical Trials Office - Children's Hospitals and Clinics of Minnesota
Ph: 612-813-5193
 Masonic Cancer Center at University of Minnesota
 Clinical Trials Office - Masonic Cancer Center at University of Minnesota
Ph: 612-624-2620
  Rochester
 Mayo Clinic Cancer Center
 Clinical Trials Office - All Mayo Clinic Locations
Ph: 507-538-7623
Mississippi
  Jackson
 University of Mississippi Cancer Clinic
 Gail Megason
Ph: 601-984-5220
Missouri
  Kansas City
 Children's Mercy Hospital
 Maxine Hetherington
Ph: 816-234-3265
  St. Louis
 Cardinal Glennon Children's Hospital
 William Ferguson
Ph: 314-577-5638
 Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
 Robert Hayashi
Ph: 314-454-2041
Nevada
  Las Vegas
 CCOP - Nevada Cancer Research Foundation
 Jonathan Bernstein
Ph: 702-732-1493
New Jersey
  Hackensack
 Hackensack University Medical Center Cancer Center
 Clinical Trials Office - Hackensack University Medical Center Cancer Center
Ph: 201-996-2879
  Morristown
 Overlook Hospital
 Steven Halpern
Ph: 973-971-6720
  Newark
 Newark Beth Israel Medical Center
 Clinical Trials Office - Newark Beth Israel Medical Center
Ph: 973-926-3136
New Mexico
  Albuquerque
 University of New Mexico Cancer Center
 Clinical Trials Office - University of New Mexico Cancer Center
Ph: 505-272-6972
New York
  Brooklyn
 Maimonides Cancer Center at Maimonides Medical Center
 Contact Person
Ph: 718-765-2520
  New York
 Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
 Clinical Trials Office - Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
Ph: 212-305-8615
  Syracuse
 SUNY Upstate Medical University Hospital
 Clinical Trials Office - SUNY Upstate Medical University Hospital
Ph: 315-464-5476
  Valhalla
 New York Medical College
 Mehmet Ozkaynak
Ph: 914-493-7997
North Carolina
  Charlotte
 Presbyterian Cancer Center at Presbyterian Hospital
 Clinical Trials Office - Presbyterian Cancer Center at Presbyterian Hospital
Ph: 704-384-5369
  Durham
 Duke Cancer Institute
 Clinical Trials Office - Duke Cancer Institute
Ph: 888-275-3853
  Winston-Salem
 Wake Forest University Comprehensive Cancer Center
 Clinical Trials Office - Wake Forest University Comprehensive Cancer Center
Ph: 336-713-6771
Ohio
  Cincinnati
 Cincinnati Children's Hospital Medical Center
 Clinical Trials Office - Cincinnati Children's Hospital Medical Center
Ph: 513-636-2799
  Cleveland
 Cleveland Clinic Taussig Cancer Center
 Clinical Trials Office - Cleveland Clinic Taussig Cancer Center
Ph: 866-223-8100
 Rainbow Babies and Children's Hospital
 Yousif (Joe) Matloub
Ph: 216-844-3345
  Columbus
 Nationwide Children's Hospital
 Laura Martin
Ph: 614-722-3582
Oklahoma
  Oklahoma City
 Oklahoma University Cancer Institute
 Rene McNall-Knapp
Ph: 405-271-5311
Oregon
  Portland
 Knight Cancer Institute at Oregon Health and Science University
 Clinical Trials Office - Knight Cancer Institute at Oregon Health and Science University
Ph: 503-494-1080
  Email: trials@ohsu.edu
 Legacy Emanuel Children's Hospital
 Clinical Trials Office - Legacy Emanuel Children's Hospital
Ph: 503-413-2560
Pennsylvania
  Bethlehem
 Lehigh Valley Hospital - Muhlenberg
 Philip Monteleone
Ph: 484-884-3333
  Danville
 Geisinger Cancer Institute at Geisinger Health
 Clinical Trials Office - Geisinger Cancer Institute
Ph: 570-271-5251
  Pittsburgh
 Children's Hospital of Pittsburgh of UPMC
 Clinical Trials Office - Children's Hospital of Pittsburgh
Ph: 412-692-7056
Rhode Island
  Providence
 Rhode Island Hospital Comprehensive Cancer Center
 Clinical Trials Office - Rhode Island Hospital Comprehensive Cancer Center
Ph: 401-444-1488
South Dakota
  Sioux Falls
 Sanford Cancer Center at Sanford USD Medical Center
 Clinical Trials Office - Sanford Cancer Center
Ph: 605-328-1367
Tennessee
  Knoxville
 East Tennessee Children's Hospital
 Ray Pais
Ph: 865-541-8266
Texas
  Corpus Christi
 Driscoll Children's Hospital
 Clinical Trials Office - Driscoll Children's Hospital
Ph: 361-694-5311
  Dallas
 Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
 Clinical Trials Office - Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
Ph: 866-460-4673; 214-648-7097
  San Antonio
 Methodist Children's Hospital of South Texas
 Jaime Estrada
Ph: 210-575-7268
 University of Texas Health Science Center at San Antonio
 Paul Thomas
Ph: 210-567-7477
Virginia
  Falls Church
 Inova Fairfax Hospital
 Clinical Trials Office - Inova Fairfax Hospital
Ph: 703-208-6650
  Norfolk
 Children's Hospital of The King's Daughters
 Eric Lowe
Ph: 757-668-7243
  Richmond
 Virginia Commonwealth University Massey Cancer Center
 Clinical Trials Office -Virginia Commonwealth University Massey Cancer Center
Ph: 804-628-1939
Washington
  Seattle
 Children's Hospital and Regional Medical Center - Seattle
 Julie Park
Ph: 206-987-2106
  Spokane
 Providence Cancer Center at Sacred Heart Medical Center
 Judy Felgenhauer
Ph: 509-474-2777
Wisconsin
  Green Bay
 St. Vincent Hospital Regional Cancer Center
 Clinical Trials Office - St. Vincent Hospital Regional Cancer Center
Ph: 920-433-8889
  Marshfield
 Marshfield Clinic - Marshfield Center
 Clinical Trials Office - Marshfield Clinic - Marshfield Center
Ph: 800-782-1581 ext. 94457
Australia
Western Australia
  Perth
 Princess Margaret Hospital for Children
 Catherine Cole
Ph: 011-6189340-8238
Canada
British Columbia
  Vancouver
 Children's and Women's Hospital of British Columbia
 Caron Strahlendorf
Ph: 604-875-3576
Manitoba
  Winnipeg
 CancerCare Manitoba
 Rochelle Yanofsky
Ph: 204-787-4163
Nova Scotia
  Halifax
 IWK Health Centre
 Margaret Yhap
Ph: 902-470-8778
Ontario
  Ottawa
 Children's Hospital of Eastern Ontario
 Jacqueline Halton
Ph: 613-737-7600x2370
  Toronto
 Hospital for Sick Children
 Sylvain Baruchel
Ph: 416-813-7795
Quebec
  Montreal
 Hopital Sainte Justine
 Yvan Samson
Ph: 514-345-4969
  Quebec
 Centre Hospitalier Universitaire de Quebec
 Bruno Michon
Ph: 418-656-4141X47191
Saskatchewan
  Saskatoon
 Saskatoon Cancer Centre at the University of Saskatchewan
 Christopher Mpofu
Ph: 306-655-2744

Registry Information
Official Title A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Trial Start Date 2007-05-07
Trial Completion Date 2009-05-06 (estimated)
Registered in ClinicalTrials.gov NCT00458887
Date Submitted to PDQ 2007-02-26
Information Last Verified 2012-02-14
NCI Grant/Contract Number CA095861

Note: The purpose of most clinical trials listed in this database is to test new cancer treatments, or new methods of diagnosing, screening, or preventing cancer. Because all potentially harmful side effects are not known before a trial is conducted, dose and schedule modifications may be required for participants if they develop side effects from the treatment or test. The therapy or test described in this clinical trial is intended for use by clinical oncologists in carefully structured settings, and may not prove to be more effective than standard treatment. A responsible investigator associated with this clinical trial should be consulted before using this protocol.

Back to TopBack to Top